Pain Management Approach
Pain management should begin with a 0-10 numerical rating scale assessment asking specifically "What has been your worst pain in the last 24 hours?", followed by scheduled (not PRN) multimodal analgesia combining non-opioid medications (acetaminophen and NSAIDs) with opioids when indicated, using around-the-clock dosing rather than as-needed administration for persistent pain. 1
Initial Assessment Framework
Pain Quantification
- Use a 0-10 numerical rating scale to assess three specific parameters: current pain, worst pain in past 24 hours, and usual pain 2, 1
- If worst pain scores ≥3 or the patient reports distress, proceed to comprehensive evaluation 2
- For patients scoring <3, continue monitoring 2
Comprehensive Pain Characterization
Document the following specific elements:
- Pain characteristics: severity, type (nociceptive vs neuropathic), location, radiation pattern, quality descriptors 2, 1
- Temporal factors: onset, duration, course, exacerbating and relieving factors 2, 1
- Functional impact: identify specific activities the patient cannot currently perform rather than focusing solely on pain scores 2, 1
Biopsychosocial Assessment
Evaluate three domains systematically:
Physical/Biological factors 2, 1:
- Underlying pathology requiring treatment
- Current inflammation or joint damage
- Physical disability and mobility limitations
- Sleep disturbance patterns
- Obesity and general fitness level
- Comorbidities (renal/hepatic disease, respiratory conditions)
Psychological factors 2:
- Pain-related beliefs and catastrophizing cognitions
- Fear of movement or activity avoidance
- Psychological distress or psychiatric comorbidity
- Patient's understanding of pain and treatment expectations
Social factors 2:
- Impact on work, family relationships, and social participation
- Economic concerns and housing situation
- Cultural and linguistic considerations
- Substance use history (tobacco, alcohol, illicit drugs)
Treatment Algorithm
Step 1: First-Line Interventions
Initiate multimodal non-opioid therapy as the foundation 1:
Scheduled medications (not PRN):
- Acetaminophen: 1000 mg every 6-8 hours, given regularly from treatment initiation 3
- NSAIDs: Ibuprofen 400-600 mg every 6-8 hours or naproxen 250-500 mg twice daily if no contraindications 3, 4
- Start NSAIDs at lowest effective dose; for naproxen, initial dose should not exceed 1250 mg/day, with maintenance not exceeding 1000 mg/day 4
Nonpharmacologic interventions 2, 1:
- Physical therapy and exercise programs
- Cognitive behavioral therapy for chronic pain
- Relaxation techniques, guided imagery, breathing exercises
- Heat, ice, elevation, compression as appropriate
Step 2: Opioid Initiation (When Non-Opioids Insufficient)
Critical principle: Use around-the-clock scheduled dosing, not PRN, for persistent pain 3
For opioid-naïve patients 5:
- Start with short-acting opioids: morphine 5-15 mg oral or 2-5 mg IV
- Provide rescue doses at 10-20% of 24-hour total, available every 1-2 hours 5
- If patient requires ≥4 rescue doses in 24 hours, increase scheduled baseline dose 5
- Calculate total 24-hour opioid consumption (scheduled + all PRN doses)
- Increase both around-the-clock and PRN doses by 25-50% based on this total
- Reassess within 24-48 hours after any dose adjustment
Step 3: Special Population Considerations
Patients with substance abuse history 2:
- Do NOT withhold opioids for legitimate pain—addiction is rarely a problem when treating cancer or acute pain 2
- Reassure patient that addiction history will not prevent adequate pain management 2
- Use higher doses at shorter intervals due to cross-tolerance 2
- Avoid mixed agonist-antagonist opioids (may precipitate withdrawal) 2
- Notify addiction treatment program of hospitalization and medications given 2
Patients on methadone maintenance 2:
- Continue usual methadone maintenance dose (verify with clinic)
- Add separate short-acting opioids for acute pain
- Do not use maintenance methadone dose for analgesia
Patients on buprenorphine maintenance 2: For acute pain, choose one of four options:
- Continue buprenorphine and titrate short-acting opioids (short-duration pain only)
- Divide buprenorphine to every 6-8 hours
- Discontinue buprenorphine, use opioid analgesics, convert back when pain resolves
- (Inpatients only) Switch to methadone 20-40 mg with short-acting opioids, convert back before discharge
Patients with respiratory disease 4:
- NSAIDs contraindicated if history of aspirin-induced asthma or bronchospasm 4
- Use lowest effective opioid doses with close respiratory monitoring
- Consider non-opioid adjuvants (gabapentin for neuropathic components)
Monitoring and Reassessment
Regular Assessment Schedule
- Daily assessment during initial titration phase 5
- Within 24-48 hours after any dose adjustment 3
- Stable patients: ongoing monitoring using "Four A's" framework 1
Four A's Monitoring Framework 1:
- Analgesia: Is pain adequately controlled?
- Activities of daily living: Is function improving?
- Adverse effects: Monitor sedation, constipation, nausea, respiratory depression
- Aberrant drug taking: Watch for concerning behaviors
Patient Education Requirements
Provide written instructions including 2, 3:
- Exact dosing schedule for each medication
- List of potential side effects and management strategies
- Medications to discontinue
- Expected timeline for pain improvement
- Contact numbers and specific callback criteria
Critical callback criteria 2, 3:
- New or worsening pain despite medications
- Nausea/vomiting preventing eating for >24 hours
- No bowel movement for 3 days
- Difficulty arousing patient during daytime
- Confusion or altered mental status
- Fever, increased swelling, or other signs of complications
Essential safety messages 2:
- Take potent analgesics only as prescribed
- Do not self-adjust doses without provider discussion
- Do not mix with alcohol or illicit substances
- Properly safeguard controlled substances in the home
- Expect constipation—start stool softeners/laxatives prophylactically
Critical Pitfalls to Avoid
Never rely solely on pain intensity scores—pain is multidimensional and requires assessment of functional impact and patient-centered goals 1
Never use PRN-only dosing for persistent pain—around-the-clock scheduled dosing is essential for continuous pain control 3
Never ignore underlying treatable causes—providing only analgesics without addressing pathology (e.g., spinal cord compression, infection) is inappropriate 1
Never undertreate high-risk patients—early intensive management reduces long-term disability 1
Never assume opioids will cause addiction in pain patients—when used appropriately for cancer or acute pain, addiction is rarely a problem 2
Never withhold opioids due to psychiatric symptoms—failure to control pain may worsen delirium and psychiatric symptoms 5